Инфицированность вирусом папилломы человека при патологиях полового члена (систематический обзор литературы)
Загрузок: 60
Просмотров: 200
pdf

Ключевые слова

ВПЧ
рак полового члена
ВПЧ высокого канцерогенного риска
вакцинация при ВПЧ

Как цитировать

Гаптулбарова, К. А., Ибрагимова , М. К., & Литвяков, Н. В. (2023). Инфицированность вирусом папилломы человека при патологиях полового члена (систематический обзор литературы). Вопросы онкологии, 69(5), 815–823. https://doi.org/10.37469/0507-3758-2023-69-5-815-823

Аннотация

Введение. Этиология рака полового члена (РПЧ) является многофакторной, в частности, интересным вопросом является ассоциация инфицирования вирусом папилломы человека (ВПЧ) с риском развития рака полового члена. Имеющиеся в литературе результаты по выявлению ВПЧ при новообразованиях полового члена очень противоречивы по сравнению с аналогичными при других ВПЧ-ассоциированных онкопатологиях.

Цель исследования. Систематизация имеющихся мировых литературных данных относительно связи наличия ВПЧ-инфекции с риском возникновения рака полового члена.

Материалы и методы. Поиск проводился с помощью баз данных Pubmed, NCBI и поискового сервиса Google scholar. В результате литературного поиска первично было получено 205 статей по изучаемой тематике, опубликованных с 1991 по 2020 гг. В окончательный анализ вошли 9 исследований, соответствующие абсолютно всем заданным параметрам.

Результаты. Показано, что ВПЧ определяется почти в равной степени как при доброкачественных образованиях и предраковых поражениях полового члена, так и среди образцов нормальной ткани полового члена (контрольных групп). В то время как имеется значительное отличие в количестве ВПЧ-положительных пациентов среди больных с диагнозом рак полового члена и контрольной группой, OR = 142,6. Также определено, что самыми распространёнными генотипами ВПЧ высокого канцерогенного риска (ВКР) оказались 16 и 18.

Заключение. Результаты систематического обзора подтвердили высокую степень риска возникновения РПЧ при наличии ВПЧ инфекции, а также высокий уровень инфицированности ВПЧ при РПЧ (62,0 %).

https://doi.org/10.37469/0507-3758-2023-69-5-815-823
Загрузок: 60
Просмотров: 200
pdf

Библиографические ссылки

Kidd LC. Chaing S, Chipolliniet J, et al. Relationship between human papillomavirus and penile cancer—implications for prevention and treatment. Translational andrology and urology. 2017;6(5):791. https://doi.org/10.21037/tau.2017.06.27.

Kombe Kombe AJ, Li B, Zahid A, et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Frontiers in Public Health. 2021;8:1003. https://doi.org/10.3389/fpubh.2020.552028.

Pow-Sang MR, Ferreira U, Pow-Sang JM, et al. Epidemiology and natural history of penile cancer. Urology. 2010;76(2):S2-S6. https://doi.org/10.1016/j.urology.2010.03.003.

Аксель ЕМ, Матвеев ВБ. Статистика злокачественных новообразований мочевых и мужских половых органов в России и странах бывшего СССР. Онкоурология. 2019;15(2):15-24 [Axel EM, Matveev VВ. Statistics of malignant tumors of urinary and male urogenital organs in Russia and the countries of the former USSR. Cancer Urology. 2019;15(2):15-24 (In Russ.)]. https://doi.org/10.17650/1726-9776-2019-15-2-15-24.

Брико НИ, Лопухов ПД, Каприн АД, и др. ВПЧ-ассоциированные поражения в Российской Федерации: оценка состояния проблемы. Современная онкология. 2019;21(1):45-50 [Briko NI, Lopukhov PD, Kaprin AD, et al. HPV-associated lesions in the Russian Federation: assessment of the problem. Journal of Modern Oncology. 2019;21(1):45-50 (In Russ.)]. https://doi.org/10.26442/18151434.2019.190199.

Schlenker B, Schneede P. The role of human papilloma virus in penile cancer prevention and new therapeutic agents. European Urology Focus. 2019;5(1):42-5. http://dx.doi.org/10.1016/j.euf.2018.09.010

Brouwer OR, Albersen M, Parnham A, et al. European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update. European Urology. 2023;83(6):548-60. http://dx.doi.org/10.1016/j.eururo.2023.02.027.

Moch H, Amin MB, Berney DM, et al. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs—part a: renal, penile, and testicular tumours. European Urology. 2022;82(5):458-68. http://dx.doi.org/10.1016/j.eururo.2022.06.016.

Brouwer OR, Albersen M, Parnham A, et al. European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update, Eur Urol. 2023;83(Issue6):548-560. https://doi.org/10.1016/j.eururo.2023.02.027.

Lu B, Wu Y, Nielson CM, et al. Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of us men: a prospective study. The Journal of Infectious Diseases. 2009;199(3):362-71. http://dx.doi.org/10.1086/596050.

Giuliano AR, Lee J-H, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. The Lancet. 2011;377(9769):932-40. http://dx.doi.org/10.1016/s0140-6736(10)62342-2.

Kayes O, Ahmed HU, Arya M, et al. Molecular and genetic pathways in penile cancer. The Lancet Oncology. 2007;8(5):420-9. http://dx.doi.org/10.1016/s1470-2045(07)70137-7.

Backes DM, Kurman RJ, Pimenta JM, et al. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes & Control. 2008;20(4):449-57. http://dx.doi.org/10.1007/s10552-008-9276-9.

Dai B, Ye D-W, Zhu Y-P, et al. Relationship between circumcision and human papillomavirus infection: a systematic review and meta-analysis. Asian Journal of Andrology. 2017;19(1):125. http://dx.doi.org/10.4103/1008-682x.175092.

Iorga L, Marcu R, Diaconu C, et al. Penile carcinoma and HPV infection (Review). Experimental and Therapeutic Medicine. 2020;20(1):91-96. http://dx.doi.org/10.3892/etm.2019.8181.

Wolbarst AbrL. Circumcision And Penile Cancer. The Lancet. 1932;219(5655):150-3. http://dx.doi.org/10.1016/s0140-6736(01)24346-3.

Hebnes JB, Munk C, Frederiksen K, et al. The role of circumcision, tobacco, and alcohol use in genital human papillomavirus infection among men from Denmark. Int J STD AIDS. 2021;32(11):1028-1035. https://doi.org/10.1177/09564624211014727.

Saibishkumar EP, Crook J, Sweet J. Neonatal circumcision and invasive squamous cell carcinoma of the penis: a report of 3 cases and a review of the literature. Canadian Urological Association Journal. 2013;2(1):39. http://dx.doi.org/10.5489/cuaj.525.

Harder T, Wichmann O, Klug SJ, et al. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review. BMC Medicine. 2018;16(1). http://dx.doi.org/10.1186/s12916-018-1098-3.

Giuliano AR, Viscidi R, Torres BN, et al. Seroconversion following anal and genital HPV infection in men: The HIM study. Papillomavirus Research. 2015;1:109-15. http://dx.doi.org/10.1016/j.pvr.2015.06.007.

Hillman RJ, Giuliano AR, Palefsky JM, et al. Immunogenicity of the quadrivalent human papillomavirus (Type 6/11/16/18) vaccine in males 16 to 26 years old. Clinical and Vaccine Immunology. 2012;19(2):261-7. http://dx.doi.org/10.1128/cvi.05208-11.

Glombik D, Oxelbark Å, Sundqvist P, et al. Risk of second HPV-associated cancers in men with penile cancer. Acta Oncologica. 2021;60(5):667-71. http://dx.doi.org/10.1080/0284186x.2021.1885056.

Araújo LA de, De Paula AAP, de Paula H da SC, et al. Human papillomavirus (HPV) genotype distribution in penile carcinoma: Association with clinic pathological factors. Tornesello ML, editor. PloS one. 2018;13(6):e0199557. http://dx.doi.org/10.1371/journal.pone.0199557.

Gu W, Zhang P, Zhang G, et al. Importance of HPV in chinese penile cancer: a contemporary multicenter study. Frontiers in Oncology. 2020;10. http://dx.doi.org/10.3389/fonc.2020.01521.

Varma VA, Sanchez-Lanier M, Unger ER, et al. Association of human papillomavirus with penile carcinoma: A study using polymerase chain reaction and in situ hybridization. Human Pathology. 1991;22(9):908-13. http://dx.doi.org/10.1016/0046-8177(91)90181-n.

Iwasawa A, Kumamoto Y, Fujinaga K. Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. Journal of Urology. 1993;149(1):59-63. http://dx.doi.org/10.1016/s0022-5347(17)35999-2.

Suzuki H, Sato N, Kodama T, et al. Detection of human papillomavirus DNA and state of p53 gene in Japanese penile cancer. Jpn J Clin Oncol. 1994;24(1):1-6.

Gregoire L, Cubilla AL, Reuter VE, et al. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst. 1995;87(22):1705-9. http://dx.doi.org/10.1093/jnci/87.22.17.05.

Bezerra AL, Lopes A, Santiago GH, et al. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer. 2001;91(12):2315-21.

Humbey O, Cairey-Remonnay S, Guérrini JS, et al. Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas. European Journal of Cancer. 2003;39(5):684-90. http://dx.doi.org/10.1016/s0959-8049(02)00835-3.

Lont AP, Kroon BK, Horenblas S, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer. 2006;119(5):1078-81. http://dx.doi.org/10.1002/ijc.21961.

Senba M, Kumatori A, Fujita S, et al. The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. Journal of Medical Virology. 2006;78(10):1341-6. http://dx.doi.org/10.1002/jmv.20703.

Prowse DM, Ktori EN, Chandrasekaran D, et al. Human papillomavirus-associated increase in p16INK4A expression in penile lichen sclerosus and squamous cell carcinoma. British Journal of Dermatology. 2007;158(2):261-5. http://dx.doi.org/10.1111/j.1365-2133.2007.08305.x.

Scheiner MA, Campos MM, Ornellas AA, et al. Human papillomavirus and penile cancers in Rio de Janeiro, Brazil: HPV typing and clinical features. International braz j urol. 2008;34(4):467-76. http://dx.doi.org/10.1590/s1677-55382008000400009.

Guerrero D, Guarch R, Ojer A, et al. Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma. BJU International [Internet]. 2008;102(6):747-55. http://dx.doi.org/10.1111/j.1464-410x.2008.07603.x.

Yanagawa N, Osakabe M, Hayashi M, et al. Detection of HPV-DNA,p53alterations, and methylation in penile squamous cell carcinoma in Japanese men. Pathol Int. 2008;58(8):477-82. http://dx.doi.org/10.1111/j.1440-1827.2008.02259.x.

Tornesello ML, Duraturo ML, Losito S, et al. Human papillomavirus genotypes and HPV16 variants in penile carcinoma. International Journal of Cancer. 2007;122(1):132-7. http://dx.doi.org/10.1002/ijc.23062.

Krustrup D, Jensen HL, van den Brule AJC, et al. Histological characteristics of human papilloma-virus-positive and -negative invasive andin situsquamous cell tumours of the penis. International J Exp Pathol. 2009;90(2):182-9. http://dx.doi.org/10.1111/j.1365-2613.2008.00636.x.

Cubilla AL, Lloveras B, Alejo M, et al. The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from paraguay. Am J Surg Pathol. 2010;34(1):104-14. http://dx.doi.org/10.1097/pas.0b013e3181c76a49.

D’Hauwers KWM, Depuydt CE, Bogers JJ, et al. Human papillomavirus, lichen sclerosus and penile cancer: A study in Belgium. Vaccine. 2012;30(46):6573-7. http://dx.doi.org/10.1016/j.vaccine.2012.08.034.

Cubilla AL, Lloveras B, Alemany L, et al. Basaloid squamous cell carcinoma of the penis with papillary features. Am J Surg Pathol. 2012;36(6):869-75. http://dx.doi.org/10.1097/pas.0b013e318249c6f3

Do HTT, Koriyama C, Khan NA, et al. The etiologic role of human papillomavirus in penile cancers: a study in Vietnam. British Journal of Cancer. 2013;108(1):229-33. http://dx.doi.org/10.1038/bjc.2012.583.

Hernandez BY, Goodman MT, Unger ER, et al. Human Papillomavirus Genotype Prevalence in Invasive Penile Cancers from a Registry-Based United States Population. Frontiers in Oncology. 2014;4. http://dx.doi.org/10.3389/fonc.2014.00009.

Lebelo RL, Boulet G, Nkosi CM, et al. Diversity of HPV types in cancerous and pre-cancerous penile lesions of South African men: Implications for future HPV vaccination strategies. Journal of Medical Virology. 2013;86(2):257-65. http://dx.doi.org/10.1002/jmv.23730.

Steinestel J, Al Ghazal A, Arndt A, et al. The role of histologic subtype, p16INK4a expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma. BMC Cancer. 2015;15(1). http://dx.doi.org/10.1186/s12885-015-1268-z.

Djajadiningrat RS, Jordanova ES, Kroon BK, et al. Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome. Journal of Urology. 2015;193(2):526-31. http://dx.doi.org/10.1016/j.juro.2014.08.087.

Singh P, Sharma P, Panaiyadiyan S, et al. Association of human papillomavirus in penile cancer: A single-center analysis. Indian Journal of Urology. 2022;38(3):210. http://dx.doi.org/10.4103/iju.iju_41_22

Miralles-Guri C, Bruni L, Cubilla AL, et al. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol. 2009;62(10):870-8. http://dx.doi.org/10.1136/jcp.2008.063149.

Fai EK, Bhutta HA, Ali K. Progression of a Buschke-Lowenstein tumor into invasive squamous cell carcinoma. JAAPA. 2019 Jun;32(6):1-4. http://dx.doi.org/10.1097/01.JAA.0000554740.24182.ae.

Haycox CL, Kuypers J, Krieger JN. Role of human papillomavirus typing in diagnosis and clinical decision making for a giant verrucous genital lesion. Urology. 1999;53(3):627-30. http://dx.doi.org/10.1016/s0090-4295(98)00351-3.

Sherman RN, Fung HK, Flynn KJ. Verrucous carcinoma (Buschke-Lowenstein tumor). Int J Dermatol. 1991;30(10):730-3. http://dx.doi.org/10.1111/j.1365-4362.1991.tb02622.x.

Pilotti S, Donghi R, D'Amato L, et al. HPV detection and p53 alteration in squamous cell verrucous malignancies of the lower genital tract. Diagn Mol Pathol. 1993;2(4):248-56.

Castrén K, Vähäkangas K, Heikkinen E, et al. Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein. Int J Cancer. 1998;77(5):674-8. http://dx.doi.org/10.1002/(sici)1097-0215(19980831)77:5<674::aid-ijc2>3.0.co;2-s.

Sasidharanpillai S, Ravishankar N, Kamath V, et al. Prevalence of human papillomavirus (HPV) DNA among men with oropharyngeal and anogenital cancers: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2021;22(5):1351-64. http://dx.doi.org/10.31557/apjcp.2021.22.5.1351.

Pan LJ, Ma JH, Zhang FL, et al. [HPV infection of the external genitalia in men whose female partners have cervical HPV infection (Chinese)]. Zhonghua Nan Ke Xue. 2018;24(6):516-519.

Beder Ribeiro CM, Ferrer I, Santos de Farias AB, et al. Oral and genital HPV genotypic concordance between sexual partners. Clinical Oral Investigations. 2013;18(1):261-8. http://dx.doi.org/10.1007/s00784-013-0959-6.

Hellberg D, Valentin J, Eklund T, et al. Penile cancer: is there an epidemiological role for smoking and sexual behaviour? BMJ. 1987;295(6609):1306-8. http://dx.doi.org/10.1136/bmj.295.6609.1306.

Maden C, Sherman KJ, Beckmann AM, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. JNCI Journal of the National Cancer Institute. 1993;85(1):19-24. http://dx.doi.org/10.1093/jnci/85.1.19.

Лицензия Creative Commons

Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.

© АННМО «Вопросы онкологии», Copyright (c) 2023